Clinical trial
Rapid Versus Conventional Titration of Quetiapine in…
NCT00457899 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00457899 |
|---|---|
| Title | Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder |
| Official title | RAPID-An Open-Label Randomized, Multicenter Phase IIIb Study to Evaluate the Efficacy and Tolerability of Quetiapine IR (Immediate Release), Over 14 Days, in Acute Schizophrenia/Schizoaffective Disorder (Rapid Versus Conventional Titration) |
| Acronym | RAPID |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorders, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Quetiapine IR (Immediate Release) |
| Enrollment | 234 |
| Start date | Jul 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 9, 2007 |
| Last update posted | Nov 27, 2007 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: